In January of this year, the FDA noted that it had "received adverse event reports after patients used compounded semaglutide" and that "patients should not use a compounded drug if an approved drug is available to treat a patient." In July, the agency followed up with a notice that it had "received reports of adverse events, some requiring hospitalization, that may be related to overdoses due to dosing errors associated with compounded semaglutide injectable products." And in August, Eli Lilly, the maker of Zepbound and Mounjaro, sent a series of cease-and-desist letters to providers urging them to stop prescribing compounded versions of those drugs
Cautions and warnings: Cautions and warnings: Consult a health-care practitioner prior to use if you are pregnant or breast-feeding
The 28-Day Rule Even though bacteriostatic water contains a preservative, most clinical guidelines suggest discarding a reconstituted vial after 28 days
Without insurance, a monthly supply of Wegovy can cost around $1,349, but programs like "We Go Together" offer significant savings for those with or without insurance
10 NCBI BookshelfBest practices for subcutaneous injection: aseptic technique and site rotation